Contravisory Investment Management’s Bruker BRKR Stock Holding History

Contravisory Investment Management’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-30	Closed	-$1K	–	443
2017 Q3	$1K	Buy	+30	New	+$864	﹤0.01%	396

Other funds holding BRKR

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Contravisory Investment Management's BRKR Position: Q4 2017 in Review

Contravisory Investment Management sold out of Bruker (BRKR) in Q4 2017, closing a stake of 30 shares — an estimated $1K sold.

Contravisory Investment Management first reported a position in BRKR in Q3 2017 and held it in 1 quarter. The position peaked at $1K in Q3 2017. 233 funds tracked by Wall St. Rank hold BRKR as of Q4 2017.

Contravisory Investment Management reported no remaining Bruker position as of Q4 2017 after selling out during the quarter.
Contravisory Investment Management sold 30 Bruker shares in Q4 2017, an estimated $1K.
Contravisory Investment Management first reported a position in Bruker in Q3 2017 and held it in 1 quarter.
Contravisory Investment Management's Bruker position peaked at $1K in Q3 2017.
233 funds tracked by Wall St. Rank held Bruker as of Q4 2017.

Based on Contravisory Investment Management's 13F filing for Q4 2017, filed 18 Jan 2018.